Board approves conversion of 465000 warrants into equity shares
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.4 pts less than Nifty Microcap 250 and 4.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Shelter Pharma's Board approved conversion of 465,000 warrants into 465,000 equity shares at Rs. 42.25 each on October 16, 2026. Promoter Mustaqim Nisarahmed Sabugar exercised all balance warrants, paying Rs. 14.73 lakh as remaining 75% exercise price. Paid-up capital rose from Rs. 16.84 crore to Rs. 17.30 crore (1.68 crore to 1.73 crore shares). No warrants remain outstanding.
Minor dilution from promoter-led warrant conversion; no fresh capital beyond already-committed amount. Signals promoter confidence.